EGFR and non-small cell lung carcinoma: The study of non-squamous NSCLC patients who received surgical resection, which evaluated clinicopathologic features of EGFR mutation, suggested that lymphatic permeation was lower in tumors harboring EGFR mutations (37.0% vs. 41.9%, p < 0.001) [22].